Evidence map›Paper›PMID 28669401›Full record

ArticleAmerican journal of human genetics2017

A Fast Association Test for Identifying Pathogenic Variants Involved in Rare Diseases.

Daniel Greene, NIHR BioResource, Sylvia Richardson, Ernest Turro

Open access · hybridAbstract read
In one paragraph

Article in American journal of human genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Biallelic variants inmedRxiv : the preprint server for health sciences · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Machine learning in rare disease.Nature methods · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Hemostatic phenotypes and genetic disorders.Research and practice in thrombosis and haemostasis · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Bayesian Inference Associates RareCirculation. Genomic and precision medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Daniel GreeneDepartment of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0XY, UK; NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge CB2 0PT, UK; Medical Research Council Biostatistics Unit, Cambridge Biomedical Campus, Cambridge CB2 0SR, UK. Electronic address: dg333@cam.ac.uk.
NIHR BioResource
Sylvia RichardsonMedical Research Council Biostatistics Unit, Cambridge Biomedical Campus, Cambridge CB2 0SR, UK.
Ernest TurroDepartment of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0XY, UK; NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge CB2 0PT, UK; Medical Research Council Biostatistics Unit, Cambridge Biomedical Campus, Cambridge CB2 0SR, UK.
Medical Research Council · GBNHS Blood and Transplant · GBUniversity of Cambridge · GB

Funding

Medical Research Council MC_UP_0801/1Medical Research Council MC_UU_00002/10
6 · The paper itself

Abstract

We present a rapid and powerful inference procedure for identifying loci associated with rare hereditary disorders using Bayesian model comparison. Under a baseline model, disease risk is fixed across all individuals in a study. Under an association model, disease risk depends on a latent bipartition of rare variants into pathogenic and non-pathogenic variants, the number of pathogenic alleles that each individual carries, and the mode of inheritance. A parameter indicating presence of an association and the parameters representing the pathogenicity of each variant and the mode of inheritance can be inferred in a Bayesian framework. Variant-specific prior information derived from allele frequency databases, consequence prediction algorithms, or genomic datasets can be integrated into the inference. Association models can be fitted to different subsets of variants in a locus and compared using a model selection procedure. This procedure can improve inference if only a particular class of variants confers disease risk and can suggest particular disease etiologies related to that class. We show that our method, called BeviMed, is more powerful and informative than existing rare variant association methods in the context of dominant and recessive disorders. The high computational efficiency of our algorithm makes it feasible to test for associations in the large non-coding fraction of the genome. We have applied BeviMed to whole-genome sequencing data from 6,586 individuals with diverse rare diseases. We show that it can identify multiple loci involved in rare diseases, while correctly inferring the modes of inheritance, the likely pathogenic variants, and the variant classes responsible.

Indexed as

Genetic Predisposition to DiseaseGenetic VariationGenome-Wide Association StudyCardiomyopathiesComputer SimulationGenetic LociHumansImmunologic Deficiency SyndromesIntercellular Signaling Peptides and ProteinsNuclear ProteinsOsteochondrodysplasiasPrimary Immunodeficiency DiseasesProbabilityRare DiseasesRetinal DiseasesThrombocytopeniaANKRD26 protein, humanIntercellular Signaling Peptides and ProteinsNuclear ProteinsBayesian inferencehereditary disordersMendelian diseasesrare diseasesrare variant association testrare variantswhole-genome sequencing

Identifiers

PMID28669401
PMCPMC5501869
OpenAlexW2724944290

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.